Profil
Rick Modi is Chief Executive Officer & Director at Affinia Therapeutics, Inc. since 2019.
Former positions include Associate Director-Sales & Marketing at Centocor, Inc. from 2002 to 2008; Senior Director & Vice President at MedImmune LLC from 2008 to 2013; Associate Director-Global Market Development at Janssen Biotech, Inc.; Senior Vice President-Global Marketing at InterMune, Inc. from 2013 to 2015; Chief Business Officer at Astria Therapeutics, Inc. from 2015 to 2017; and Chief Business Officer & Senior Vice President at Novartis Gene Therapies, Inc. from 2017 to 2019.
Education includes undergraduate studies at the University of Iowa and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Rick Modi
| Unternehmen | Position | Beginn |
|---|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Vorstandsvorsitzender | 01.08.2019 |
Ehemalige bekannte Positionen von Rick Modi
| Unternehmen | Position | Ende |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | 01.07.2019 |
| ASTRIA THERAPEUTICS, INC. | Corporate Officer/Principal | 10.02.2017 |
| INTERMUNE INC | Corporate Officer/Principal | 01.01.2015 |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01.07.2013 |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Vertrieb & Marketing | 01.02.2008 |
Ausbildung von Rick Modi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Biotech, Inc.
Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
















